3/A

PRIMARY DOCUMENT

Company: ENANTA PHARMACEUTICALS INC
Filed: November 14, 2017
Period of Report: January 30, 2014
Accession Number: 0001177648-17-000036

View Document ↗ View on SEC.gov ↗